RH131609 |
W146 |
W146 is a selective antagonist of sphingosine-1-phosphate receptor 1 (S1PR1) wit
|
RH131699 |
AZD4144 |
AZD4144 is an orally active NLRP3 inhibitor.
|
RH131700 |
VER-246608 |
VER-246608 is a potent and ATP-competitive inhibitor of pyruvate dehydrogenase k
|
RH131701 |
RMC-7977 |
RMC-7977 is a highly selective inhibitor of the active (GTP-bound) forms of KRAS
|
RH131702 |
Ml-60218 |
ML-60218 is a broad-spectrum RNA pol III inhibitor, with IC50s of 32 and 27 μM f
|
RH131703 |
Docosahexaenoic acid (DHA) |
Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and
|
RH131704 |
LY2452473 |
LY2452473 is an orally bioavailable, selective androgen receptor modulator (SARM
|
RH131705 |
GSK1521498 free base |
GSK1521498 free base is a potent and selective μ-opioid receptor (MOR) antagonis
|
RH131706 |
Fast Violet B Salt |
Fast Violet B Salt
|
RH132013 |
BGB-16673 |
Catadegbrutinib (BTK-IN-29) (compound 14) is an inhibitor of Btk.
|
RH132014 |
VX993 |
Sodium Channel inhibitor 6 (compound I) is a sodium channel inhibitor that can b
|
RH132015 |
SR-2890 |
WEE1 DEGRADATION INHIBITORS
|
RH132016 |
Acoramidis(AG10) |
Acoramidis (AG10) is an orally active and selective kinetic stabilizer of WT and
|
RH132017 |
PF-07328948 |
PF-07328948 is an orally effective BDK (branch chain ketoacid dehydrog
|
RH132018 |
LY-3299178 |
LY-3299178
|
RH132019 |
PF-07265807 |
PF-07265807
|
RH132020 |
E-4031 |
E-4031 is a selective hERG potassium channel blocker for use in class III anti-a
|
RH132021 |
4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole |
ABD-F, a thiol-reactive fluorogenic reagent, is employed for the detection and q
|
RH132022 |
IAG933(YAP-TEAD-IN-3) |
IAG933 (YAP-TEAD-IN-3) is an orally available YAP/TAZ-TEAD inhibitor。 IAG933 YAP
|
RH132023 |
Luteolin |
Luteolin (Luteoline), a flavanoid compound, is a potent Nrf2 inhibitor.
|
RH132024 |
MAC glucuronide linker-1 |
MAC glucuronide linker-1 is a claevable ADC linker for antibody-agent-conjugatio
|
RH132025 |
Tuspetinib (HM43239) |
Tuspetinib (HM43239) is an orally active and selective FLT3 inhibitor with IC50s
|
RH132026 |
PF-06679142 |
PF-06679142 (Compound 10) is a potent, orally active AMPK activator with an EC50
|
RH132027 |
PRT062607(P505-15) |
PRT062607(P505-15; PRT-2607; BIIB-057) is a highly specific and potent inhibitor
|
RH132028 |
Dotinurad |
Dotinurad ((3,5-dichloro-4-hydroxyphenyl)(1,1-dioxidobenzo[d]thiazol-3(2H)-yl)me
|